These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28861905)

  • 1. Treatable inherited rare movement disorders.
    Jinnah HA; Albanese A; Bhatia KP; Cardoso F; Da Prat G; de Koning TJ; Espay AJ; Fung V; Garcia-Ruiz PJ; Gershanik O; Jankovic J; Kaji R; Kotschet K; Marras C; Miyasaki JM; Morgante F; Munchau A; Pal PK; Rodriguez Oroz MC; Rodríguez-Violante M; Schöls L; Stamelou M; Tijssen M; Uribe Roca C; de la Cerda A; Gatto EM;
    Mov Disord; 2018 Jan; 33(1):21-35. PubMed ID: 28861905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in clinical trials for movement disorders.
    Kieburtz K; Olanow CW
    Mov Disord; 2015 Sep; 30(11):1580-7. PubMed ID: 26307591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Hereditary and Acquired Rare Choreas.
    Martinez-Ramirez D; Walker RH; Rodríguez-Violante M; Gatto EM;
    Tremor Other Hyperkinet Mov (N Y); 2020 Aug; 10():24. PubMed ID: 32832197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Movement Disorders in Children.
    Pearson TS; Pons R
    Continuum (Minneap Minn); 2019 Aug; 25(4):1099-1120. PubMed ID: 31356295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges associated with clinical trials for inherited and orphan retinal diseases.
    Fishman GA
    Retina; 2005 Dec; 25(8 Suppl):S10-S12. PubMed ID: 16374308
    [No Abstract]   [Full Text] [Related]  

  • 7. Movement Disorders and Neurometabolic Diseases.
    Christensen CK; Walsh L
    Semin Pediatr Neurol; 2018 Apr; 25():82-91. PubMed ID: 29735120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milestones in movement disorders clinical trials: advances and landmark studies.
    Olanow CW; Wunderle KB; Kieburtz K
    Mov Disord; 2011 May; 26(6):1003-14. PubMed ID: 21626545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings of the First International Symposium on Translational Clinical Research for Inherited and Orphan Retinal Diseases. November 5-7, 2004. Washington, DC, USA.
    Retina; 2005 Dec; 25(8 Suppl):S1-113. PubMed ID: 16509005
    [No Abstract]   [Full Text] [Related]  

  • 10. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force.
    Marras C; Lang A; van de Warrenburg BP; Sue CM; Tabrizi SJ; Bertram L; Mercimek-Mahmutoglu S; Ebrahimi-Fakhari D; Warner TT; Durr A; Assmann B; Lohmann K; Kostic V; Klein C
    Mov Disord; 2016 Apr; 31(4):436-57. PubMed ID: 27079681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New treatments in movement disorders].
    Kulisevsky J
    Neurologia; 1999 Dec; 14 Suppl 6():46-72. PubMed ID: 10659605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network of patients with orphan retinal diseases for clinical trials: goals, structure, challenges.
    Weleber RG
    Retina; 2005 Dec; 25(8 Suppl):S66-S67. PubMed ID: 16374344
    [No Abstract]   [Full Text] [Related]  

  • 13. Movement disorders: insights into mechanisms and hopes for treatment.
    Wider C; Wszolek ZK
    Lancet Neurol; 2009 Jan; 8(1):8-10. PubMed ID: 19081502
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene, stem cell, and future therapies for orphan diseases.
    Phillips MI
    Clin Pharmacol Ther; 2012 Aug; 92(2):182-92. PubMed ID: 22739143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatable Movement Disorders of Infancy and Early Childhood.
    Aravamuthan BR; Pearson TS
    Semin Neurol; 2020 Apr; 40(2):177-191. PubMed ID: 32079029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of movement disorders-rare but important].
    Klebe S; Timmann D
    Nervenarzt; 2019 Feb; 90(2):197-210. PubMed ID: 30645659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurometabolic disorders are treatable causes of dystonia.
    Kuiper A; Eggink H; Tijssen MA; de Koning TJ
    Rev Neurol (Paris); 2016; 172(8-9):455-464. PubMed ID: 27561437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History, Trial Readiness and Gene Discovery: Advances in Patient Registries for Neuromuscular Disease.
    Thompson R; Robertson A; Lochmüller H
    Adv Exp Med Biol; 2017; 1031():97-124. PubMed ID: 29214567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is new in movement disorders?
    Poewe W
    Wien Klin Wochenschr; 1999 Sep; 111(17):664-71. PubMed ID: 10526391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
    Krishnan ML; Berry-Kravis E; Capal JK; Carpenter R; Gringras P; Hipp JF; Miller MT; Mingorance A; Philpot BD; Pletcher MT; Rotenberg A; Tjeertes J; Wang PP; Willgoss T; de Wit MC; Jeste SS
    Nat Rev Drug Discov; 2021 Sep; 20(9):653-654. PubMed ID: 34002058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.